Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCVSCVS Health
FinDog View：Bullish
MRKMerck & Co.
FinDog View：Neutral
| Metric | CVS | MRK |
|---|
| Close | 90.25 | 149.52 |
| Market Cap | $116B | $371B |
| 1M | +5.32% | +2.90% |
| P/E (TTM) | 23.8 | 117.2 |
| Forward P/E | 10.4 | 19.6 |
| P/E 5-Yr Percentile | 65 | 81 |
| P/S | 0.3 | 5.6 |
| P/B | 1.5 | 8.9 |
| Dividend Yield | 3.49% | 2.87% |
| Latest Quarter Revenue | $106B | $16.6B |
| Revenue YoY | +7.3% | +5.1% |
| Gross Margin | 44.5% | 73.5% |
| Latest Quarter EPS | 2.31 | -0.54 |
| Avg Post-Earnings Move | ±2.3% | ±1.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.94% | 3.37% |
| 90-Day Net Insider Buying | — | −$30.0M |
CVS · Revenue, Last 8 Quarters ($B)
MRK · Revenue, Last 8 Quarters ($B)
